MiNK Therapeutics, Inc. (INKT) Social Stream
MINK THERAPEUTICS INC (INKT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering INKT.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-09 | 4 | $30 | $24 | $26.666 | $2.29 | 1064.45% |
2022-03-21 | 4 | $30 | $10 | $22 | $2.29 | 860.7% |
2022-05-11 | 4 | $30 | $7 | $21 | $2.29 | 817.03% |
2022-11-06 | 5 | $30 | $7 | $17.5 | $2.29 | 664.19% |
2022-11-14 | 3 | $7 | $7 | $7 | $2.29 | 205.68% |
INKT reports an average of 796.17% for its upside potential over the past 34 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-05-11 | 5 | 30 | 7 | 21.0 | 1.29 | 1527.91% |
2022-05-11 | 4 | 30 | 7 | 21.0 | 1.29 | 1527.91% |
2022-11-03 | 5 | 30 | 7 | 17.5 | 2.25 | 677.78% |
2022-11-06 | 5 | 7 | 7 | 7.0 | 2.44 | 186.89% |
2022-11-06 | 5 | 30 | 7 | 17.5 | 2.44 | 617.21% |
INKT Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
INKT's average broker recommendation rating improved by 0 over the prior 35 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, MINK THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 653.8% of them.
- MINK THERAPEUTICS INC's variance in analysts' estimates is lower than -278.81% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, MINK THERAPEUTICS INC's number of analysts covering the stock is higher than 164.51% of them.
- MINK THERAPEUTICS INC's average analyst price target is greater than 213.03% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MINK THERAPEUTICS INC are AURA, CMPX, and VIGL.
View All Top Stocks by Price Target
What is the outlook for INKT? Use POWR Ratings for clearer insight into price direction.